Max Robotics — Global Service Robot Directory + US Certification

About

Paul D. Gobardhan is a leading figure in the advancement of minimally invasive liver surgery, with a focused expertise in hepatobiliary oncology and surgical innovation. His major contributions center on improving oncologic outcomes through the integration of cutting-edge technologies. Most notably, his 2024 work on ICG-fluorescence imaging for margin assessment during minimally invasive colorectal liver metastasis resection (49 citations) addresses the critical challenge of unintended tumor-positive margins, demonstrating how real-time fluorescence guidance can enhance surgical precision. Dr. Gobardhan has also been instrumental in evaluating the comparative effectiveness of robotic versus laparoscopic approaches. His nationwide propensity-matched analysis (12 citations) provides robust evidence on the benefits of robotic liver resection, while his subsequent study on conversion risk factors (8 citations) offers vital insights into patient selection and operative safety. By leveraging large-scale national data, his research directly informs clinical decision-making, helping surgeons minimize conversions and optimize patient outcomes. Through these high-impact studies, Dr. Gobardhan is shaping the future of minimally invasive liver surgery, making complex procedures safer and more effective for patients with liver malignancies.